MedTrace Logo

The Effect of Colchicine on Platelet Function Profiles in Patients With Stable Coronary Artery Disease

NCT06567678 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2025-08-11

No results posted yet for this study

Summary

The effects of colchicine on cardiovascular health in patients with stable coronary artery disease have been shown to be beneficial due to its anti-inflammatory properties. This present study aims to explore the effects of colchicine on platelet reactivity in patients with coronary artery disease on dual antiplatelet therapy.

Conditions

Interventions

DRUG

Colchicine 0.5 MG oral tablet twice daily

Blood samples will be collected from participants in 2 separate instances. Initially, a baseline VerifyNow P2Y12 PRU and Aspirin reaction unit test assay, followed by a subsequent repeat test 2-week after a 2-week, colchicine 0.5mg oral tablet twice-daily

Sponsors & Collaborators

  • The University of The West Indies

    lead OTHER

Principal Investigators

  • Naveen Seecheran · The University of The west Indies, Saint Augustine, Trinidad and Tobago.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-08-21
Primary Completion
2024-10-20
Completion
2024-11-04
FDA Drug
Yes

Countries

  • Trinidad and Tobago

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06567678 on ClinicalTrials.gov